|
| |
|
Drug Information and Specification T1, Predominantly positive enhancement PHARMACOKINETIC Intravascular, extracellular, renal excretion CONCENTRATION 0.5 mol/L, 279.3mg/ml PREPARATION Finished product INDICATION Neuro/whole body DEVELOPMENT STAGE For sale PRESENTATION Vials of 5, 10, 15 and 20 mL
Glass syringes of 5, 10, 15 and 17 mL DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information TERRITORY TRADE NAME DEVELOPMENT STAGE DISTRIBUTOR Australia ProHance® for sale | |
|
| • View the DATABASE results for 'ProHance®' (6).
| |
| | Further Reading: | | Basics:
|
|
News & More:
| |
| |